Opening Asia for Russia

Japan may approve another COVID-19 vaccine in late spring

07.03.2021 40 просмотров

Japan may approve a second coronavirus vaccine in May.

The Japanese government may approve the use of another coronavirus vaccine in the country in May this year. This was announced on Sunday by the Minister of Health, Labor and Welfare of Japan Norihisa Tamura.

“There is a possibility that the regulator will approve [another vaccine] in mid-May or June,” leads his words to the Kyodo agency. In February, the Japanese Ministry of Health approved the use of the drug by the American company Pfizer (Pfizer).

To date, the British-Swedish pharmaceutical company AstraZeneca (AstraZeneca) and the American company Moderna have also filed applications for registration of their vaccines in Japan. "Modern".

Vaccination in Japan began on February 17th. At the first stage, 40 thousand medical workers were vaccinated, later this process should cover about 4.7 million Japanese doctors. At the second stage, residents of the country over 65 years of age, of whom there are about 36 million in Japan, will be allowed to be vaccinated. By May, vaccines may become available to other categories of citizens.

To date, according to Japanese authorities, since vaccination in the country, there were two cases of anaphylactic reactions to the drug from Pfizer. Those vaccinated had a severe allergic reaction within a short time after vaccination, but after taking the necessary medicines, their condition improved. The Japanese Ministry of Health is currently investigating both cases.

Новости партнёров